Physical and Genetic Interaction Landscape of the Tyrosine Kinome

酪氨酸激酶的物理和遗传相互作用景观

基本信息

项目摘要

DESCRIPTION (provided by applicant): Signaling by tyrosine kinases play a major role in mammalian signal transduction and is a major component of nearly every major disease type. However, a systematic understanding of signaling pathways has remained elusive. While a number of techniques have been developed to map signaling pathways, used alone they only provide insight into one facet of signaling. We will use an integrative approach to chart the networks which control tyrosine kinase signaling at multiple levels through the use of complementary physical and genetic interaction mapping approaches. These maps will lead to network models which reflect proteins that can functionally modulate signaling and are physically associated with kinases including substrates, adaptors and regulatory subunits. To achieve this, the proposal integrates the complementary expertise of investigators at the University of California-San Francisco in high-throughput physical and genetic interaction mapping (Krogan), chemical-genetic approaches for tracing signaling pathways (Shokat) and network analysis and data integration (Bandyopadhyay). We aim to identify proteins that associate with tyrosine kinases through affinity purification-mass spectrometry (AP-MS) and kinase substrates through covalent capture-and-release in Aim 1. These data will be further characterized using a newly developed platform for quantitative genetic interaction mapping in mammalian cells, which will establish the functional relevance of these interactions by systematically identifying epistatic genetic relationships between kinases and associated proteins in Aim 2. Lastly, in Aim 3, we will unify data collected in the first two aims using network modeling to uncover detailed, mechanistic biological insights relating to mammalian tyrosine kinases. All data (raw, processed and integrated) will be made immediately available in an interactive and searchable fashion so that others can exploit the information we have collected on the tyrosine kinome.
描述(由申请人提供): 酪氨酸激酶的信号在哺乳动物信号转导中起主要作用,并且是几乎每种主要疾病类型的主要组成部分。但是,对信号通路的系统理解仍然难以捉摸。尽管已经开发了许多技术来绘制信号通路,但仅使用它们仅提供对信号传导一个方面的洞察力。我们将使用一种集成方法来绘制网络,通过使用互补的物理和遗传相互作用映射方法来控制酪氨酸激酶信号在多个级别上的网络。这些地图将导致网络模型,这些网络模型反映了可以在功能上调节信号传导的蛋白质,并与包括底物,适配器和调节亚基在内的激酶物理相关。为了实现这一目标,该提案将加州大学弗朗西斯科大学研究人员的补充专业知识整合在高通量的物理和遗传相互作用映射(Krogan),用于追踪信号通路(SHOKAT)的化学基因方法(SHOKAT)以及网络分析和数据集成(Bandyopadhyay)。 We aim to identify proteins that associate with tyrosine kinases through affinity purification-mass spectrometry (AP-MS) and kinase substrates through covalent capture-and-release in Aim 1. These data will be further characterized using a newly developed platform for quantitative genetic interaction mapping in mammalian cells, which will establish the functional relevance of these interactions by systematically identifying epistatic genetic relationships between kinases and associated proteins in AIM 2。最后,在AIM 3中,我们将使用网络建模在前两个目标中统一数据,以发现与哺乳动物酪氨酸激酶有关的详细的机械生物学见解。所有数据(原始,处理和集成)将以交互式和可搜索的方式立即提供,以便其他数据可以利用我们在酪氨酸Kinome上收集的信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sourav Bandyopadhyay其他文献

Sourav Bandyopadhyay的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sourav Bandyopadhyay', 18)}}的其他基金

Bay Area Cancer Target Discovery and Development
湾区癌症靶标的发现和开发
  • 批准号:
    10704172
  • 财政年份:
    2022
  • 资助金额:
    $ 44.02万
  • 项目类别:
Bay Area Cancer Target Discovery and Development
湾区癌症靶标的发现和开发
  • 批准号:
    10504993
  • 财政年份:
    2022
  • 资助金额:
    $ 44.02万
  • 项目类别:
Stress responses drive resistance and shape tumor evolution in EGFR mutant lung cancer
应激反应驱动EGFR突变肺癌的耐药性并塑造肿瘤进化
  • 批准号:
    10329992
  • 财政年份:
    2020
  • 资助金额:
    $ 44.02万
  • 项目类别:
Stress responses drive resistance and shape tumor evolution in EGFR mutant lung cancer
应激反应驱动EGFR突变肺癌的耐药性并塑造肿瘤进化
  • 批准号:
    9887321
  • 财政年份:
    2020
  • 资助金额:
    $ 44.02万
  • 项目类别:
Stress responses drive resistance and shape tumor evolution in EGFR mutant lung cancer
应激反应驱动EGFR突变肺癌的耐药性并塑造肿瘤进化
  • 批准号:
    10552632
  • 财政年份:
    2020
  • 资助金额:
    $ 44.02万
  • 项目类别:
The Cancer Target Discovery and Development Network at UCSF
加州大学旧金山分校癌症靶标发现和开发网络
  • 批准号:
    9753177
  • 财政年份:
    2017
  • 资助金额:
    $ 44.02万
  • 项目类别:
Organoid Acquired Resistance
类器官获得性抗性
  • 批准号:
    10517262
  • 财政年份:
    2017
  • 资助金额:
    $ 44.02万
  • 项目类别:
The Cancer Target Discovery and Development Network at UCSF
加州大学旧金山分校癌症靶标发现和开发网络
  • 批准号:
    10210200
  • 财政年份:
    2017
  • 资助金额:
    $ 44.02万
  • 项目类别:
Organoid Acquired Resistance
类器官获得性抗性
  • 批准号:
    10705134
  • 财政年份:
    2017
  • 资助金额:
    $ 44.02万
  • 项目类别:
Physical and Genetic Interaction Landscape of the Tyrosine Kinome
酪氨酸激酶的物理和遗传相互作用景观
  • 批准号:
    8697650
  • 财政年份:
    2014
  • 资助金额:
    $ 44.02万
  • 项目类别:

相似国自然基金

基于亲和导向-邻近反应的复杂体系天然蛋白固定新方法及色谱评价
  • 批准号:
    22374116
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
基于亲和色谱策略筛选和挖掘磷酸酶PP2A新型调节剂
  • 批准号:
    22377149
  • 批准年份:
    2023
  • 资助金额:
    50.00 万元
  • 项目类别:
    面上项目
基于仿生亲和色谱-质谱策略的肺结核患者血清抗体谱研究
  • 批准号:
    82160027
  • 批准年份:
    2021
  • 资助金额:
    34 万元
  • 项目类别:
    地区科学基金项目
基于亲和色谱靶点“钩钓”策略研究补肾活血方抗AGEs诱导神经损伤的作用机制
  • 批准号:
    82104621
  • 批准年份:
    2021
  • 资助金额:
    24.00 万元
  • 项目类别:
    青年科学基金项目
固定化单构象态受体亲和色谱的建立及止喘灵方平喘功效物质研究
  • 批准号:
    82174088
  • 批准年份:
    2021
  • 资助金额:
    55.00 万元
  • 项目类别:
    面上项目

相似海外基金

Proteasome Inhibitor-Loaded Antibody Drug Conjugates with High Drug Loading For Targeted Treatment of Triple Negative Breast Cancers
负载蛋白酶体抑制剂的高载药量抗体药物偶联物用于三阴性乳腺癌的靶向治疗
  • 批准号:
    10822628
  • 财政年份:
    2023
  • 资助金额:
    $ 44.02万
  • 项目类别:
Enhanced delivery of site-specific DNA damaging toxins to prostate cancercells
增强向前列腺癌细胞输送特定位点 DNA 损伤毒素
  • 批准号:
    10654187
  • 财政年份:
    2023
  • 资助金额:
    $ 44.02万
  • 项目类别:
Defining intracellular mitochondrial heterogeneity establishment and maintenance
定义细胞内线粒体异质性的建立和维持
  • 批准号:
    10436786
  • 财政年份:
    2021
  • 资助金额:
    $ 44.02万
  • 项目类别:
Molecular modulators of polycystin signaling
多囊蛋白信号传导的分子调节剂
  • 批准号:
    10078607
  • 财政年份:
    2019
  • 资助金额:
    $ 44.02万
  • 项目类别:
Molecular modulators of polycystin signaling
多囊蛋白信号传导的分子调节剂
  • 批准号:
    10373144
  • 财政年份:
    2019
  • 资助金额:
    $ 44.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了